InvestorsHub Logo
Followers 118
Posts 20251
Boards Moderated 0
Alias Born 06/13/2011

Re: rosemountbomber post# 15958

Wednesday, 11/09/2022 7:39:13 PM

Wednesday, November 09, 2022 7:39:13 PM

Post# of 17403
A little update on that Lupkynis script … the first if it happens at my wife’s hospital ( one of the largest in Nth Ca ) .
Insurers may want patient to fail Benlysta first
Severe LN with declining kidney function on the generics … Tac etc
Nephrologist wants to try Lupkynis.
Thinks insurers will require Benlysta tried first …. Less expensive and works for many
To your pt
Yes of course AUPH could cut the $ amount they charge
This is a repeat of the AMGN saga over Repatha ( which I’m on )
For the first 2 yrs AMGN wanted over $12,000 a yr
Insurers ( including mine ) refused to pay
After 2 yrs of low sales … AMGN cut the price to $4,500 …. at which time insurers ( including mine ) agreed to cover for their patients.
Now a lot more patients are now on Repatha and AMGN isn’t hurting either … chk their PPS chart

Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News